Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.325
+0.025 (1.92%)
Mar 9, 2026, 3:09 PM EDT - Market open
RANI Market Cap
RANI has a market cap or net worth of $161.02 million as of March 9, 2026. Its market cap has increased by 179.40% in one year.
Market Cap
161.02M
Enterprise Value
172.00M
1-Year Change
179.40%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $206.13M to $161.02M, a decrease of -21.88%. That is a compound annual growth rate of -5.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 126.82M | -3.70% |
| Dec 31, 2025 | 131.69M | 188.57% |
| Dec 31, 2024 | 45.64M | -46.89% |
| Dec 29, 2023 | 85.92M | -41.09% |
| Dec 30, 2022 | 145.85M | -54.75% |
| Dec 31, 2021 | 322.29M | 56.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 175.94M |
| Tonix Pharmaceuticals Holding | 172.08M |
| Caribou Biosciences | 170.11M |
| Jyong Biotech | 166.10M |
| Karyopharm Therapeutics | 160.88M |
| Milestone Pharmaceuticals | 160.50M |
| Immunic | 160.47M |
| Fate Therapeutics | 154.63M |